Doubling Pharma Value With Data Science
A once-in-a-generation opportunity has opened to digitally redesign a core part of the biopharma business. Capturing the opportunity requires vision and leadership; it’s not about the technology.
You may also be interested in...
A plethora of clinical studies are showing that new types of data, often captured in the EHR, can help improve the correlation between treatments and outcomes and favorably affect patient care as well as enhance drug development.
Biopharma and medtech companies are using patient information across the product lifecycle to make evidence generation agile and virtual, and to move beyond single products toward end-to-end patient management.